Recruiting Interstitial Lung Disease Studies in Ann Arbor
About Interstitial Lung Disease Clinical Trials in Ann Arbor
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 13 interstitial lung disease clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 2,983 participants. Research is being sponsored by University of Pittsburgh, University of Massachusetts, Worcester, University of Michigan and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Ann Arbor — FAQ
Are there interstitial lung disease clinical trials in Ann Arbor?
Yes, there are 13 interstitial lung disease clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 13 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 14, 2026 from ClinicalTrials.gov